Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Finished Goods: 2021-2024

Historic Finished Goods for Organogenesis Holdings (ORGO) over the last 4 years, with Dec 2024 value amounting to $12.0 million.

  • Organogenesis Holdings' Finished Goods rose 87.48% to $24.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.4 million, marking a year-over-year increase of 87.48%. This contributed to the annual value of $12.0 million for FY2024, which is 16.68% down from last year.
  • As of FY2024, Organogenesis Holdings' Finished Goods stood at $12.0 million, which was down 16.68% from $14.5 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Finished Goods registered a high of $15.0 million during FY2021, and its lowest value of $11.5 million during FY2022.
  • Moreover, its 3-year median value for Finished Goods was $12.0 million (2024), whereas its average is $12.7 million.
  • Its Finished Goods has fluctuated over the past 5 years, first declined by 23.51% in 2022, then climbed by 25.93% in 2023.
  • Yearly analysis of 4 years shows Organogenesis Holdings' Finished Goods stood at $15.0 million in 2021, then fell by 23.51% to $11.5 million in 2022, then rose by 25.93% to $14.5 million in 2023, then fell by 16.68% to $12.0 million in 2024.